Risk of Hepatitis B reactivation in patients receiving Ibrutinib: The national Veterans Affairs Cohort

Abstract: BACKGROUND: Ibrutinib has been a first-line treatment for chronic lymphocytic leukemia since 2014. Case reports of hepatitis B virus (HBV) reactivation after ibrutinib …